Delivery Order SPE2DR25D2215-SPE2DR26F1MCW
- Not listed
- The Defense Logistics Agency awarded a $40,182 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Zepbound 7.5 mg/0.5 ml pen injections. This competitively awarded, non-set-aside contract with an ultimate completion date of January 22, 2026, represents a task order under AmerisourceBergen's parent company Cencora Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. The...
- The Defense Logistics Agency awarded a delivery order valued at $7,232.76 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injections on January 26, 2026, with completion scheduled for January 27, 2026. This non-competitive delivery order was issued under a firm fixed-price structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $46,832.34 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight...
- The Defense Logistics Agency awarded a $11,201.00 delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.77 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on February 2, 2026, with completion scheduled for February 3, 2026. This firm fixed-price order was competitively awarded without set-aside restrictions and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication used for weight management, reflecting the Defense...
- The Defense Logistics Agency awarded a $9,342.91 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 7, 2026. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,136.11 on January 13, 2026, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This non-competitive delivery order represents a firm fixed-price purchase against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,769.92 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injections, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Zepbound, a semaglutide-based medication for weight management, supports military healthcare needs through the...
- The Defense Logistics Agency awarded a delivery order valued at $87,471.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections on January 14, 2026. This is a firm fixed-price, non-set-aside contract with a completion date of January 15, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a $17,870.69 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on January 7, 2026, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract performed at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DR25D2215Indefinite Delivery Contract
- SPE2DR25D2215-SPE2DR26F1MCWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,607.32 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections on February 3, 2026, with completion scheduled for February 4, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performance-based in Conshohocken, Pennsylvania, where the vendor's corporate office is located. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the vehicle for this pharmaceutical procurement. Zepbound is a semaglutide-based medication used for weight management in adults, and this order supports federal healthcare supply requirements for military treatment facilities and other government medical systems. AmerisourceBergen Drug Corp, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that regularly fulfills federal medical procurement needs through its comprehensive contract portfolio with the Defense Logistics Agency. The company's extensive experience delivering brand-name and generic medications, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains positions it as a critical vendor for the department's global pharmaceutical support operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/2/26 |